• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床诊断的特发性正常压力脑积水与阿尔茨海默病之间脑脊液生物标志物的差异

Differences in Cerebrospinal Fluid Biomarkers between Clinically Diagnosed Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease.

作者信息

Tsai Andrew, Malek-Ahmadi Michael, Kahlon Vickram, Sabbagh Marwan N

机构信息

The Cleo Roberts Center for Clinical Research, Banner-Sun Health Research Institute, AZ, USA.

出版信息

J Alzheimers Dis Parkinsonism. 2014 May 30;4(4). doi: 10.4172/2161-0460.1000150.

DOI:10.4172/2161-0460.1000150
PMID:25937995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4415860/
Abstract

OBJECTIVE

In the present study, cerebrospinal fluid (CSF) profiles were assessed to determine how idiopathic normal pressure hydrocephalus (NPH) and Alzheimer's disease (AD) differs.

METHODS

Subjects were drawn from patients who underwent lumbar punctures as part of their diagnostic evaluations in the Banner Sun Health Research Institute Memory Disorders clinic. The clinical sample included 11 iNPH subjects (mean age 81.36±2.58) and 11 AD subjects (mean age 61.46±8.24). Concentrations of amyloid-β (Aβ42), total-tau (t-tau), phospho-tau181 (p-tau) Aβ42, and an Aβ42-Tau Index (ATI) were measured by commercial assay (Athena Diagnostics). and compared to each other. The Mann-Whitney test was used to assess group differences on the raw values for Aβ42, t-tau, p-tau, ATI, age, education, and MMSE.

RESULTS

In a univariate analysis, p-tau was found to be significantly (P = 0.009) lower in patients diagnosed with iNPH than those with AD. Amyloid-β (Aβ42), total-tau (t-tau) did not differ between groups. In multi-variate analysis, the differences in p-tau between groups did not differ.

CONCLUSION

Although age could represent a significant confound, p-tau is significantly lower in iNPH compared to AD. P-tau would be expected to increase with age but in this sample is lower suggesting the difference might be explained by the underlying condition.

摘要

目的

在本研究中,评估脑脊液(CSF)特征以确定特发性正常压力脑积水(NPH)与阿尔茨海默病(AD)之间的差异。

方法

研究对象来自班纳太阳健康研究所记忆障碍诊所接受腰椎穿刺作为诊断评估一部分的患者。临床样本包括11名特发性正常压力脑积水患者(平均年龄81.36±2.58岁)和11名阿尔茨海默病患者(平均年龄61.46±8.24岁)。通过商业检测法(雅典娜诊断公司)测量淀粉样蛋白β(Aβ42)、总tau蛋白(t-tau)、磷酸化tau181(p-tau)Aβ42和Aβ42 - Tau指数(ATI),并进行相互比较。采用曼 - 惠特尼检验评估Aβ42、t-tau、p-tau、ATI、年龄、教育程度和简易精神状态检查表(MMSE)原始值的组间差异。

结果

在单变量分析中,发现被诊断为特发性正常压力脑积水的患者的p-tau显著低于阿尔茨海默病患者(P = 0.009)。淀粉样蛋白β(Aβ42)、总tau蛋白(t-tau)在两组之间没有差异。在多变量分析中,两组之间p-tau的差异没有变化。

结论

尽管年龄可能是一个显著的混杂因素,但与阿尔茨海默病相比,特发性正常压力脑积水患者的p-tau显著较低。p-tau预计会随着年龄增长而增加,但在本样本中较低,这表明差异可能由潜在疾病解释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3212/4415860/630a4b5ad183/nihms658561f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3212/4415860/630a4b5ad183/nihms658561f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3212/4415860/630a4b5ad183/nihms658561f1.jpg

相似文献

1
Differences in Cerebrospinal Fluid Biomarkers between Clinically Diagnosed Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease.临床诊断的特发性正常压力脑积水与阿尔茨海默病之间脑脊液生物标志物的差异
J Alzheimers Dis Parkinsonism. 2014 May 30;4(4). doi: 10.4172/2161-0460.1000150.
2
Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.脑脊液 Aβ42、t-tau 和 p-tau 水平在特发性正常压力脑积水鉴别诊断中的作用:系统评价和荟萃分析。
Fluids Barriers CNS. 2017 May 10;14(1):13. doi: 10.1186/s12987-017-0062-5.
3
Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.特发性正常压力脑积水与阿尔茨海默病及皮质下缺血性血管病的脑脊液生物标志物:一项系统评价
J Alzheimers Dis. 2019;68(1):267-279. doi: 10.3233/JAD-180816.
4
Cerebrospinal Fluid Levels of β-Amyloid 40 and β-Amyloid 42 are Proportionately Decreased in Amyloid Positron-Emission Tomography Negative Idiopathic Normal-Pressure Hydrocephalus Patients.在淀粉样蛋白正电子发射断层扫描阴性的特发性正常压力脑积水患者中,脑脊液中β-淀粉样蛋白40和β-淀粉样蛋白42水平成比例降低。
J Clin Neurol. 2019 Jul;15(3):353-359. doi: 10.3988/jcn.2019.15.3.353.
5
Cerebrospinal Fluid Alzheimer's Biomarkers and Neurofilament Light Profile of Idiopathic Normal Pressure Hydrocephalus in China: A PUMCH Cohort Study.中国特发性正常压力脑积水的脑脊液阿尔茨海默病生物标志物和神经丝轻链特征:一项北京协和医院队列研究
Neurodegener Dis. 2020;20(5-6):165-172. doi: 10.1159/000514052. Epub 2021 Jun 2.
6
Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.特发性正常压力脑积水具有与阿尔茨海默病不同的脑脊液生物标志物谱。
J Alzheimers Dis. 2015;45(1):109-15. doi: 10.3233/JAD-142622.
7
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus.特发性正常压力脑积水患者的阿尔茨海默病脑脊液生物标志物特征
J Pers Med. 2022 Jun 6;12(6):935. doi: 10.3390/jpm12060935.
8
In Vivo Prevalence of Beta-Amyloid Pathology and Alzheimer's Disease Co-Pathology in Idiopathic Normal-Pressure Hydrocephalus-Association with Neuropsychological Features.特发性正常压力脑积水患者中β-淀粉样蛋白病理及阿尔茨海默病共病理的体内患病率——与神经心理学特征的关联
Biomedicines. 2024 Aug 20;12(8):1898. doi: 10.3390/biomedicines12081898.
9
Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study.重新审视特发性正常压力脑积水的脑脊液生物标志物特征:博洛尼亚 Pro-Hydro 研究。
J Alzheimers Dis. 2019;68(2):723-733. doi: 10.3233/JAD-181012.
10
Cerebrospinal fluid amyloid beta and response of cognition to a tap test in idiopathic normal pressure hydrocephalus: a case-control study.特发性正常压力脑积水患者脑脊液淀粉样蛋白β与认知反应对叩诊试验的影响:病例对照研究。
Int Psychogeriatr. 2023 Sep;35(9):509-517. doi: 10.1017/S1041610221000661. Epub 2021 Aug 17.

引用本文的文献

1
Analyzing the relationship between specific brain structural changes and the diffusion tensor image analysis along the perivascular space index in idiopathic normal pressure hydrocephalus.分析特发性正常压力脑积水患者特定脑结构变化与沿血管周围间隙指数的扩散张量图像分析之间的关系。
J Neurol. 2024 Dec 12;272(1):56. doi: 10.1007/s00415-024-12850-y.
2
Cerebrospinal Fluid Biomarkers in iNPH: A Narrative Review.正常压力脑积水的脑脊液生物标志物:一篇综述
Diagnostics (Basel). 2022 Nov 28;12(12):2976. doi: 10.3390/diagnostics12122976.
3
Ventricular volume in relation to lumbar CSF levels of amyloid-β 1-42, tau and phosphorylated tau in iNPH, is there a dilution effect?

本文引用的文献

1
2013 Alzheimer's disease facts and figures.2013 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2013 Mar;9(2):208-45. doi: 10.1016/j.jalz.2013.02.003.
2
Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults.认知健康的青年和老年人群中阿尔茨海默病的脑脊液标志物。
Alzheimers Dement. 2012 Nov;8(6):520-7. doi: 10.1016/j.jalz.2011.10.003. Epub 2012 Jun 6.
3
Frequency of Alzheimer's disease pathology at autopsy in patients with clinical normal pressure hydrocephalus.尸检中临床正常压力脑积水患者阿尔茨海默病病理的频率。
脑室容积与 iNPH 患者腰椎 CSF 中淀粉样蛋白-β 1-42、tau 和磷酸化 tau 的关系:是否存在稀释效应?
Fluids Barriers CNS. 2022 Jul 17;19(1):59. doi: 10.1186/s12987-022-00353-9.
4
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus.特发性正常压力脑积水患者的阿尔茨海默病脑脊液生物标志物特征
J Pers Med. 2022 Jun 6;12(6):935. doi: 10.3390/jpm12060935.
5
Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (Third Edition): Endorsed by the Japanese Society of Normal Pressure Hydrocephalus.特发性正常压力脑积水管理指南(第三版):日本正常压力脑积水学会认可。
Neurol Med Chir (Tokyo). 2021 Feb 15;61(2):63-97. doi: 10.2176/nmc.st.2020-0292. Epub 2021 Jan 15.
6
Sex determination in cremated human remains using the lateral angle of the pars petrosa ossis temporalis: is old age a limiting factor?利用颞骨岩部的外侧角对火化后的人类遗骸进行性别鉴定:高龄是否是一个限制因素?
Forensic Sci Med Pathol. 2019 Sep;15(3):392-398. doi: 10.1007/s12024-019-00131-4. Epub 2019 Jul 11.
7
Particular CSF sphingolipid patterns identify iNPH and AD patients.特定的 CSF 鞘脂模式可识别 iNPH 和 AD 患者。
Sci Rep. 2018 Sep 11;8(1):13639. doi: 10.1038/s41598-018-31756-0.
8
Cerebrospinal fluid biomarkers profile of idiopathic normal pressure hydrocephalus.特发性正常压力脑积水的脑脊液生物标志物特征。
J Neural Transm (Vienna). 2018 Apr;125(4):673-679. doi: 10.1007/s00702-018-1842-z. Epub 2018 Jan 20.
9
Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.脑脊液 Aβ42、t-tau 和 p-tau 水平在特发性正常压力脑积水鉴别诊断中的作用:系统评价和荟萃分析。
Fluids Barriers CNS. 2017 May 10;14(1):13. doi: 10.1186/s12987-017-0062-5.
10
Idiopathic Normal Pressure Hydrocephalus: A Review for General Practitioners.特发性正常压力脑积水:全科医生综述
Gerontol Geriatr Med. 2016 Apr 20;2:2333721416643702. doi: 10.1177/2333721416643702. eCollection 2016 Jan-Dec.
Alzheimers Dement. 2011 Sep;7(5):509-13. doi: 10.1016/j.jalz.2010.12.008. Epub 2011 Jul 1.
4
Biobanks for biomarkers in neurological disorders: the Da Vinci bridge for optimal clinico-pathological connection.神经疾病生物标志物生物样本库:实现最佳临床与病理联系的达·芬奇之桥。
J Neurol Sci. 2009 Aug 15;283(1-2):119-26. doi: 10.1016/j.jns.2009.02.364. Epub 2009 Mar 25.
5
Prevalence of possible idiopathic normal-pressure hydrocephalus in Japan: the Osaki-Tajiri project.日本可能的特发性正常压力脑积水患病率:尾崎-田尻项目
Neuroepidemiology. 2009;32(3):171-5. doi: 10.1159/000186501. Epub 2008 Dec 19.
6
Normal pressure hydrocephalus: diagnosis and treatment.正常压力脑积水:诊断与治疗
Curr Neurol Neurosci Rep. 2008 Sep;8(5):371-6. doi: 10.1007/s11910-008-0058-2.
7
Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease.特发性正常压力脑积水患者脑脊液中的tau蛋白、磷酸化tau181蛋白和β淀粉样蛋白1-42:与阿尔茨海默病的鉴别
Eur J Neurol. 2007 Feb;14(2):168-73. doi: 10.1111/j.1468-1331.2006.01593.x.
8
Diagnosing idiopathic normal-pressure hydrocephalus.诊断特发性正常压力脑积水。
Neurosurgery. 2005 Sep;57(3 Suppl):S4-16; discussion ii-v. doi: 10.1227/01.neu.0000168185.29659.c5.
9
Cerebrospinal fluid protein biomarkers for Alzheimer's disease.用于阿尔茨海默病的脑脊液蛋白质生物标志物。
NeuroRx. 2004 Apr;1(2):213-25. doi: 10.1602/neurorx.1.2.213.
10
Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease.脑脊液中的β淀粉样蛋白(1-42)和磷酸化tau蛋白作为早发性阿尔茨海默病的标志物。
Neurology. 2004 May 11;62(9):1580-4. doi: 10.1212/01.wnl.0000123249.58898.e0.